CTRI/2020/11/029170尚未招募未知
ignocaine nebulisation for patients with Covid -19 Respiratory infection:An Exploratory randomised double blinded controlled trial
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with PCR documented Covid -19 infection with respiratory distress(presence of hypoxia with Spo2 <93% or radiographic evidence of pneumonia,any single organ failure,sepsis)requiring supplemental oxygenation or non-invasive mechanical ventilation.
排除标准
- •1.Refusal to participate in the study
- •2.Known allergy to lignocaine
- •3.Patient requiring invasive mechanical ventilation/Septic shock
研究者
相似试验
进行中（未招募）
1 期
Treatment with inhalation of Ciclesonide for patients with coronavirus disease: A randomised open study.EUCTR2020-001928-34-SECapio S:t Görans Sjukhus446
尚未招募
2 期
se of Steroid inhalers in COVID.CTRI/2021/05/033817YOU BREATHE WE CARE
招募中
1 期
Qingjin Yiqi Granules for patients in pneumonia recovery phase (COVID-19, Omicron): a clinical studyITMCTR2200005627Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
已完成
2 期
COVID-19: Nasal spray Treatment with the well-established antiallergic Azelastine for prevention of SARS-CoV-2 INfections (CONTAIN)COVID-19 prophylaxisDRKS00031059RSAPHARM Arzneimittel GmbH450
招募中
1 期
ow Dose Radiation Therapy for COVID-19CTRI/2020/06/025862ot yet applied for funding